A Canadian Paediatric Brain Tumour Consortium (Cpbtc) Phase Ii Molecularly Targeted Study of Imatinib in Recurrent and Refractory Paediatric Central Nervous System Tumours
AuthID
P-003-G2C
P-003-G2C